AzTrials
AzTrials

Infertility of Tubal OriginNCT05209542

Hysterosalpingo-Foam Ultrasonography Combined With Power Doppler, Compared With Laparoscopy in Tubal Patency Assessment in Cases of Infertility

A study testing Hysterosalpingo-Foam Ultrasonography and Laparoscopy in people with Infertility of Tubal Origin, run by Cairo University at 1 site in Egypt.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

Women presenting with primary or secondary infertility and are undergoing investigation of tubal patency assessment will be subjected to: The examination is performed between days 5 and 10 of the menstrual cycle. Read more about this study

Who is it for?
Ages 20 to 40 years, women only
Conditions the study is for
Infertility of Tubal Origin
What is being tested?
Hysterosalpingo-Foam Ultrasonography and Laparoscopy
Could I receive a placebo?
No, everyone receives an active treatment
How many people
119 participants
Where
1 siteEgypt
Study dates
9 Feb 2018to 3 Apr 2021
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 20 to 40 years
  • Women only
  • No healthy volunteers
  • Adult

Who may be able to join

  • Sexually active women in the reproductive age group between 20 and 40 years
  • History of primary or secondary infertility ( either unexplained or suspected tubal factor by history taking )
  • Tubal factor has not been investigated before or has been investigated with inconclusive results

Who cannot join

  • Age less than 20 or above 40 years.
  • Using contraception.
  • Undiagnosed pregnancy.
  • known allergy to lidocaine.
  • active pelvic inflammatory disease or genital tract bleeding.
  • Patent both tubes as assessed previously ( no need for exposure to further Investigation.

Trial locations and contacts

1 site in 1 country.

Egypt1 site
  • Kasr Alainy medical school

    Cairo, 12151

Other trials in Egypt

About this study

Official title: Hysterosalpingo-Foam Ultrasonography Combined With Power Doppler, Compared With Laparoscopy in Tubal Patency Assessment in Cases of Infertility, (a Cross-sectional Study).

Women presenting with primary or secondary infertility and are undergoing investigation of tubal patency assessment will be subjected to:

  • The examination is performed between days 5 and 10 of the menstrual cycle.
  • Routine antibiotic prophylaxis using oral Azithromycin the day before and routine administration of NSAID rectal suppository one hour before the procedure
  • Initially, real-time 2D +/- 3D vaginal ultrasound assessment of the pelvis
  • The cervix is to be visualized with a Cusco speculum and to be cleaned with an antiseptic then A No. 5 pediatric Foley catheter will be introduced into the cervical os, using a tenaculum if necessary. The balloon is to be positioned in the lower uterine cavity and to be inflated with 2 ml of saline to prevent backflow of contrast medium through the cervix then the speculum will be removed and the vaginal transducer is going to be reintroduced in the longitudinal plane to confirm correct placement of the catheter.
  • Initial 3-5 ml of foam contrast is to be introduced slowly into the endometrial cavity while the flow of contrast medium in each tube is evaluated using grayscale and power Doppler imaging
  • Power Doppler is very helpful to confirm the direction of the flow as well as the acceleration during injection.
  • Tubal patency and quality of visualization are classified according the following parameters:
Read more
  1. Flow over the whole length of the tube, fimbrial outflow or peritoneal spillage of contrast provided definite evidence of complete (i.e. proximal and distal) tubal patency.
  2. Paracornual flow only without visualization of fimbrial outflow or peritoneal spillage suggests at least proximal patency.
  3. Contrast filling of the endometrial cavity without cornual flow suggests possible tubal occlusion.
  4. Technical difficulty making tubal evaluation impossible
  • Standard laparoscopic evaluation with the dye test (methylene blue staining) is to be performed 1 day after ultrasound tests with 1 day of hospitalization under general anesthesia.
Read the detailed description

Women in the reproductive age group between 20 and 40 years old presenting with primary or secondary infertility ( either unexplained or suspected tubal factor by history taking ) and are undergoing investigation of tubal patency assessment

Each patient in this study will be subjected to:

  • The examination is performed between days 5 and 10 of the menstrual cycle, the patient in gynecological position, preferably with the aid of one assistant.
  • Routine antibiotic prophylaxis using oral Azithromycin the day before and routine administration of NSAID rectal suppository one hour before the procedure
  • Initially, real-time 2D +/- 3D vaginal ultrasound assessment of the pelvic organs is to be performed using Samsung Elite with endovaginal probe of frequency 6-12 MHz
  • The cervix is to be visualized with a Cussco speculum and to be cleaned with an antiseptic then A No. 5 pediatric Foley catheter will be introduced into the cervical os, using a tenaculum if necessary. The balloon is to be positioned in the lower uterine cavity and to be inflated with 2 ml of saline to prevent backflow of contrast medium through the cervix then the speculum will be removed and the vaginal transducer is going to be reintroduced in the longitudinal plane to confirm correct placement of the catheter.
  • The foam contrast agent is created by combining 3-4mL of 2% lidocaine gel 12-13mL of saline and 3mL air.
  • The assistant creates the foam immediately before application, moving the mixture between two connected 20-mL syringes, until a whitish suspension is obtained (approximately 10-20 times).
  • Initial 3-5 ml of foam contrast is to be introduced slowly into the endometrial cavity while the flow of contrast medium in each tube is evaluated using grayscale and power Doppler imaging
  • Power Doppler is very helpful to confirm the direction of the flow as well as the acceleration during injection.
  • Acquisition without Doppler usually takes less than 5 s, while acquisition with power Doppler is longer(approximately 10 s)
  • After dataset acquisition, Images will be stored as 2D still images, 2D clips +/- 3D volumes. the patient is to be discharged and final diagnosis is made based on the real-time observations and, if available, offline analyses of acquired datasets.
  • Tubal patency and quality of visualization are classified according the following parameters:
  1. Flow over the whole length of the tube, fimbrial outflow or peritoneal spillage of contrast provided definite evidence of complete (i.e. proximal and distal) tubal patency.
  2. Paracornual flow only without visualization of fimbrial outflow or peritoneal spillage suggests at least proximal patency.
  3. Contrast filling of the endometrial cavity without cornual flow suggests possible tubal occlusion.
  4. Technical difficulty making tubal evaluation impossible e.g. absent filling of the endometrial cavity due to backflow of contrast, inability to introduce the catheter into the cervical os or maintain the catheter in the correct position preventing instillation of contrast into the endometrial cavity.
  • Standard laparoscopic evaluation with the dye test (methylene blue staining) is to be performed 1 day after ultrasound tests with 1 day of hospitalization under general anesthesia.
  • The raters are to be blinded to the results of the ultrasound examination until endoscopic diagnosis is to be performed
  • Comparison between the results of the above mentioned techniques will be done and statistical analysis of the results will be carried out
Being tested
Hysterosalpingo-Foam Ultrasonography, Laparoscopy

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Hysterosalpingo-Foam UltrasonographyProcedure or surgery

    • Initial 3-5 ml of foam contrast is to be introduced slowly into the endometrial cavity while the flow of contrast medium in each tube is evaluated using grayscale and power Doppler imaging
    • Power Doppler is very helpful to confirm the direction of the flow as well as the acceleration during injection
  • LaparoscopyProcedure or surgery

    • Standard laparoscopic evaluation with the dye test (methylene blue staining) is to be performed 1 day after ultrasound tests with 1 day of hospitalization under general anesthesia
Study groups in NCT05209542
Study groupRoleWhat they receive
Hysterosalpingo-Foam UltrasonographyActive comparator3-5 ml of foam contrast is to be introduced slowly into the endometrial cavity while the flow of contrast medium in each tube is evaluated using grayscale and power Doppler imaging
Receives: Procedure: Hysterosalpingo-Foam Ultrasonography; Procedure: Laparoscopy
laparoscopyActive comparator• Standard laparoscopic evaluation with the dye test (methylene blue staining) is to be performed 1 day after ultrasound tests with 1 day of hospitalization under general anesthesia
Receives: Procedure: Hysterosalpingo-Foam Ultrasonography; Procedure: Laparoscopy

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Tubal patency

    To evaluate the accuracy of Hysterosalpingo-Foam Sonography combined with Power Doppler in assessment of tubal patency in infertile women

    Measured: During the ultrasound

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted26 Jan 2022
  2. Study start9 Feb 2018
  3. Primary completion17 Feb 2020
  4. Study completion3 Apr 2021

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Diagnosis
Allocation
Non-randomised
Intervention model
Single group
Masking
None (open label)
Enrolment
119 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT05209542
Sponsor's protocol ID
63
Status last verified
Jan 2022
First submitted
13 Jan 2022
Last updated
26 Jan 2022
Results posted
No
Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
Undecided

Questions about this trial

What is this clinical trial studying?

A study testing Hysterosalpingo-Foam Ultrasonography and Laparoscopy in people with Infertility of Tubal Origin, run by Cairo University at 1 site in Egypt.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 3 inclusion and 6 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 26 Jan 2022. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Egypt. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Tubal patency (time frame: During the ultrasound). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 26 Jan 2022.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in